Nov 09, 2021 / 09:30PM GMT
Operator
Good afternoon, good evening. Welcome to the Acorda Therapeutics Third Quarter 2021 Update. (Operator Instructions) Please be advised that this call is being recorded at the company's request.
I will now introduce your host for today's call, Tierney Saccavino, from Acorda. Please go ahead.
Tierney Saccavino -
Thank you, Felicia, and good afternoon, everyone. Before we begin, let me remind you that our presentation will contain forward-looking statements. Detailed disclosures can be found in our SEC filings which are public, and we encourage you to refer to those filings. As a reminder to our callers, during the Q&A, we will only take calls from our analysts.
And I will now pass the call over to our CEO, Ron Cohen. Ron?
Ron Cohen - Acorda Therapeutics, Inc. - Founder, CEO, President & Director
Thank you, Tierney, and welcome, everyone. I'm pleased to open with late-breaking news. This afternoon, we announced that we had executed an agreement with ESTEVE to commercialize INBRIJA in Germany, which is
Q3 2021 Acorda Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot